COVID drug may also ease symptoms of long COVID
By Suzanne Leigh on May 10, 2022
An antiviral drug approved for high-risk COVID patients may also benefit those with long COVID, according to the findings of a small case series that need to be confirmed with future rigorous studies. Why doctors are prescribing nature walks
By Jillian Mock, TIME on April 27, 2022
In early April 2022, about two dozen children and their families gathered beneath the redwoods in a regional park near Oakland, Calif. They sat with a physician, Dr. Nooshin Razani, beneath the branches of the ancient giants, breathing the fresh air and discussing the phenomenon of fairy rings—when... Genomic sequencing is changing diagnosis, treatment for patients with brain cancer
By Suzanne Leigh on April 22, 2022
Patients diagnosed with a type of brain tumor survived for longer when they were treated aggressively with surgery, radiation and chemotherapy. But far from suggesting that more treatment always leads to better survival, the study by UC San Francisco underscores the critical role of genomic... Achieving Health Equity: Naming Racism and Moving to Action with Camara Phyllis Jones, MD, MPH, PhD
April 21, 2022
Camara Phyllis Jones. Credit: Kevin Grady Radcliffe Institute
California honors Bibbins-Domingo for contributions to public health
By Cameron Scott on April 21, 2022
Today Kirsten Bibbins-Domingo, MD, PhD, received the highest honor the California Department of Public Health (CDPH) offers, the Beverlee A. Myers Award for Excellence in Public Health. School segregation harms Black children’s health, well-being
By Jess Berthold on April 21, 2022
Black youth who attend racially segregated schools are more likely to have behavior problems and to drink alcohol than Black youth in less segregated schools, according to a UC San Francisco study published in Pediatrics.
Black girls were more likely than Black boys to drink alcohol in response to... Virtual cardiac rehabilitation produces similar results as in-person treatment
April 20, 2022
Cardiac rehabilitation (CR) reduces hospitalization and mortality and improves quality of life for patients with cardiovascular disease. Despite its benefits, only 24 percent of eligible patients in the U.S. participate in CR due to financial and logistical barriers. Cross-racial study of 1.87M vets shows wide disparities in dementia
By Suzanne Leigh on April 19, 2022
In what is believed to be the largest study to date on race and dementia, researchers from UC San Francisco and the San Francisco Veterans Affairs Health Care System tracked health and demographic data from close to two million veterans. It compared rates of dementia across five racial groups and... Socioeconomic status affects health across racial and ethnic groups, large study shows
By Cameron Scott on April 15, 2022
Not long ago, public health research that identified disparate outcomes between racial or ethnic groups would conclude that the difference likely had to do with the lower socioeconomic status, on average, of non-whites – with a frequent caveat that maybe there was some genetic risk f Kirsten Bibbins-Domingo, PhD, MD, MAS, to Join JAMA and the JAMA Network as Editor in Chief
By Talmadge E. King, Jr., MD on April 11, 2022